Ardent Health Inc (NYSE:ARDT)

Q2 2026 Ardent Health Inc Earnings Call Transcript

Aug 5, 2026 / 02:00 PM GMT

Release Date Price: $11.16 (+3.81%)

Transcript 10-Q8-K

Key Points

Positve

Ardent Health Inc (ARDT) successfully increased its 2026 Impact Program savings target to at least $70 million, up from the previously communicated $55 million, driven by workforce reductions and operational efficiencies.
The company reported strong cash flow generation, with second-quarter operating cash flow of $197 million, up from $117 million in the prior year, and first-half operating cash flow up 47% year-over-year.
Ardent Health Inc (ARDT) secured a key payer contract renewal in one market, expected to add $5 to $10 million to 2026 adjusted EBITDA, reflecting a broader strategy to improve revenue yield through data-driven payer negotiations.
The company demonstrated disciplined expense management, with salaries and benefits growing only 0.7% year-over-year and contract labor spend reduced by 42%, improving overall operational efficiency.
Ardent Health Inc (ARDT) is making early progress with its virtual care platform and AI capabilities, with virtual nurses completing 58% of discharges in Texas and Idaho and reducing patient monitoring hours by 18%.
The company maintains a strong balance sheet with total net leverage of 0.8 times and available liquidity of $992 million, providing flexibility for disciplined capital deployment and share repurchases.

Negative

Ardent Health Inc (ARDT) experienced broad-based volume softness in April and May, with surgeries and admissions declining 2.9% and 1% respectively in the second quarter, leading to a softer volume outlook for the rest of the year.
The company is now biased towards the lower end of its full-year 2026 revenue guidance range of $6.4 to $6.7 billion, reflecting weaker-than-expected volumes in the second quarter and conservative assumptions for the second half.
Net patient service revenue per adjusted admission decreased 3.9% year-over-year, impacted by a lower acuity service mix and the benefit of recording two quarters of the New Mexico DPP program in the prior year.
Exchange admissions declined 8% year-over-year, with a corresponding increase in self-pay volumes, contributing to a $35 million expected headwind for 2026, though actual trends have been slightly better than assumed.
The company faces ongoing pressure from professional fees and payer denials, with professional fee growth slowing but still elevated at 10.4% year-over-year, and denial trends remaining consistent with prior quarters.
Ardent Health Inc (ARDT) noted that July volumes remain below original expectations, and the company is taking a cautious approach by assuming second-quarter volume levels persist through the second half of the year.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ARDT.N - Ardent Health Inc
Q2 2026 Ardent Health Inc Earnings Call
Aug 05, 2026 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello, and thank you for standing by.

My name is Lacey and I will be your conference operator today.

At this time, I would like to welcome everyone to the Audit Help second quarter 2026 earnings conference call, all lines have been placed on mute to prevent any background noise after the speakers.

There will be a question-and-answer session.

If you would like to ask a question during this time, simply press star, followed by the number 1 on your telephone keypad.

If you would like to withdraw your question, press 1 again.

Please limit yourself to one question and one follow-up.

Thank you, I would now like to turn the call over to Dave Steidlow, senior Vice President of

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.